Genomic sequencing of multiple foci of ccRCC tumors has revealed that the majority of PBRM1 mutations occur early in tumorigenesis, while mutations in the other secondary tumor suppressor genes occur later during tumor development (Gerlinger et al., 2012, 2014). The gene discussed is PBRM1; the disease is nonpapillary renal cell carcinoma.